OPIANT PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2022 was 5.14M shares, a 15.2% increase year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 4.46M shares, a 4.86% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 4.25M shares, a 5.76% increase from 2019.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2019 was 4.02M shares, a 34.6% increase from 2018.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 5.14M +676K +15.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 5.09M +755K +17.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 5.02M +732K +17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 4.46M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 4.46M +204K +4.79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 4.33M +74.5K +1.75% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 4.28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 4.26M +209K +5.17% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 4.26M +262K +6.57% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 4.05M +1.18M +41% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 4M +1.32M +49.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q3 2018 2.87M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 2.68M +660K +32.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q2 2017 2.02M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 2.01M +97.6K +5.09% Feb 1, 2017 Apr 30, 2017 10-Q 2017-06-14
Q4 2016 2.01M +126K +6.7% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q1 2016 1.92M +86.4K +4.72% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 1.88M +74K +4.1% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q1 2015 1.83M Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 1.81M Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q2 2013 143M +39.4M +37.9% May 1, 2013 Jul 31, 2013 10-K 2013-10-29
Q1 2013 133M +35M +35.8% Feb 1, 2013 Apr 30, 2013 10-Q 2013-06-14
Q4 2012 132M +39M +42% Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-18
Q3 2012 128M +43.2M +50.9% Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-20
Q2 2012 104M +36.7M +54.7% May 1, 2012 Jul 31, 2012 10-K 2013-10-29
Q1 2012 97.9M +33.4M +51.8% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 92.8M +30M +47.8% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 84.9M +23.4M +37.9% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q2 2011 67.2M May 1, 2011 Jul 31, 2011 10-K/A 2012-11-01
Q1 2011 64.5M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 62.7M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 61.6M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.